Changes in bone Pb accumulation: Cause and effect of altered bone turnover

Bone

Volumn 64, Issue , 2014, Pages 228-234

  Brito, José A A ^a   Costa, Isabel M ^a   e Silva, Alexandra Maia ^a   Marques, José M S ^a   Zagalo, Carlos M ^a   Cavaleiro, Inês I B ^a   Fernandes, Tânia A P ^a   Gonçalves, Luísa L ^a  

^a INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

Bone turnover; Kinetic models; Osteoporosis; Pb exposure

Indexed keywords

LEAD; LEAD ACETATE; BIOLOGICAL MARKER;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; LEAD BLOOD LEVEL; LUMBAR VERTEBRA; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; RAT; TRABECULAR BONE; ANIMAL; BONE; BONE REMODELING; HALF LIFE TIME; METABOLISM; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; FEMALE; HALF-LIFE; LEAD; RATS; RATS, WISTAR;

EID: 84899831282     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.04.021     Document Type: Article

References (46)

1. Rosin A. The long-term consequences of exposure to lead. Isr Med Assoc J Nov. 2009, 11(11):689-694.
2. Mushak P. Uses and limits of empirical data in measuring and modeling human lead exposure. Environ Health Perspect Dec. 1998, 106(Suppl. 6):1467-1484.
3. Leggett R. An age-specific kinetic model of lead metabolism in humans. Environ Health Perspect 1993, 101:598-616.
4. O'Flaherty E.J. Physiologically based kinetic models for bone-seeking elements. Toxicol Appl Pharmacol 1993 Jan, 118(1):16-29.
5. Fleming D.E., Chettle D.R., Webber C.E., O'Flaherty E.J. The O'Flaherty model of lead kinetics: an evaluation using data from a lead smelter population. Toxicol Appl Pharmacol 1999, 161(1):100-109.
6. Nie H., Chettle D.R., Webber C.E., Brito J.A., O'Meara J.M., McNeill F.E. X-ray fluorescence data in the study of human bone lead metabolism. J Environ Monit 2005, 7:1069-1073.
7. Brito J.A.A., McNeill F.E., Chettle D.R., Webber C.E., Vaillancourt C. Study of the relationships between bone lead levels and its variation with time and the cumulative blood lead index, in a repeated bone lead survey. J Environ Monit 2000, 2:271-276.
8. Brito J., McNeill F.E., Chettle D.R., Webber C.E., Wells S., Richard N. Longitudinal changes in bone lead concentration: implication for modeling of human bone lead metabolism. J Environ Monit 2001, 3:343-351.
9. Brito J.A.A., McNeill F.E., Webber C.E., Chettle D.R. Grid search: an innovative method for the estimation of the rates of lead exchange between body compartments. J Environ Monit 2005, 7:241-247.
10. European Commission Report on Osteoporosis in the European Community-Action for Prevention 1998, Office for Official Publications of the European Communities, Luxembourg.
11. Monir A.U., Gundberg C.M., Yagerman S.E., van der Meulen M.C.H., Budell W.C., Boskey A.L., et al. The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone 2010, 47(5):888-894.
12. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929-1936.
13. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002, 359:1841-1850.
14. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 559:1761-1767.
15. Fitzpatrick L.A. Secondary causes of osteoporosis. Mayo Clin Proc 2002, 77:453-468.
16. Potula V., Henderson A., Kaye W. Calcitropic hormones, bone turnover, and lead exposure among female smelter workers. Arch Environ Occup Health 2005, 60(4):195-204.
17. Alfven T., Jarup L., Elinder C.G. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 2002, 110:699-702.
18. Sun Y., Sun D.H., Zhou Z.J., Zhu G.Y., Zhang H.Y., Chang X.L., et al. Osteoporosis in a Chinese population due to occupational exposure to lead. Am J Ind Med 2008, 51(6):436-442.
19. Campbell J.R., Auinger P. The association between blood lead levels and osteoporosis among adults - results from the Third National Health and Nutrition Examination Survey (NHANES III). Environ Health Perspect 2007, 115(7):1018-1022.
20. Potula V., Kleinbaum D., Kaye W. Lead exposure and spine bone mineral density. J Occup Environ Med 2006, 48(6):556-564.
21. Campbell J.R., Rosier R.N., Novotny L., Puzas J.E. The association between environmental lead exposure and bone density in children. Environ Health Perspect 2004, 112(11):1200-1203.
22. Thepeang K., Glass T.A., Bandeen-Roche K., Todd A.C., Rohde C.A., Links J.M., et al. Associations of bone mineral density and lead levels in blood, tibia, and patella in urban dwelling women. Environ Health Perspect 2008, 116(6):784-790.
23. Adachi J., Arlen D., Webber C., Chettle D., Beaumont L., Gordon C. Is there any association between the presence of bone disease and cumulative exposure to lead?. Calcif Tissue Int 1998, 63:429-432.
24. Handbook of Laboratory Animal Science 2003, Vol. II. CRC Press, Boca Raton, [Ch.10]. 2nd ed. J. Hau, G.L.V. Hoosier (Eds.).
25. Durão S.F.O., Gomes P.S., Silva-Marques J.M., Fonseca H.R.M., Carvalho J.F.C., Duarte J.A.R., et al. Bone regeneration in osteoporotic conditions: healing of subcritical-size calvarial defects in the ovariectomized rat. Int J Oral Maxillofac Implants 2012, 27:1400-1408.
26. Reed W.R., Chadha H.K., Hubscher C.H. Effects of 17 β-estradiol on responses of viscerosomatic convergent thalamic neurons in the ovariectomized female rat. J Neurophysiol 2009, 102:1062-1074.
27. Lowry N.C., Pardon L.P., Yates M.A., Juraska J.M. Effects of long term treatment with 17 β-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats. Horm Behav July 2010, 58(2):200-207.
28. Gupta D.S., Hubscher C.H. Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression. Front Physiol 2012, 3:28. 10.3389/fphys.2012.00028.
29. Osteoporosis, pathophysiology and clinical management. Series: contemporary endocrinology 2010, Humana Press, New York, NY. 2nd ed. R.A. Adler (Ed.).
30. Gundberg C.M., Lian J.B., Booth S.L. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? American Society for Nutrition. Adv Nutr 2012, 3:149-157.
31. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
32. Vasikaran S., Eastell R., Bruyère O., Foldes A.J., Garnero P., Griesmacher A., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011, 22:391-420.
33. Brito J.A.A., Cavaleiro I.I.B., Fernandes T.A.P., Gonçalves L.M.L. The feasibility of wavelength dispersive X-ray fluorescence spectrometry for the assessment of lead concentration in animal bone powder. Anal Methods 2013, 5:598-602.
34. Bellis D.J., Hetter K.M., Verostek M.F., Parsons P.J. Characterization of candidate reference materials for bone lead via interlaboratory study and double isotope dilution mass spectrometry. J Anal At Spectrom 2008, 23(3):298-308.
35. Hill P.A., Orth M. Bone remodelling. Br J Orthod 1998, 25:101-107.
36. Engqvist L. The mistreatment of covariate interaction terms in linear model analyses of behavioural and evolutionary ecology studies. Anim Behav 2005, 70:967-971.
37. Elsubeihi E.S., Bellows C.G., Jia Y., Heersche J.N.M. Ovariectomy of 12-month-old rats: effects on osteoprogenitor numbers in bone cell populations isolated from femur and on histomorphometric parameters of bone turnover in corresponding tibia. Cell Tissue Res 2007, 330:515-526.
38. Hara K., Kobayashi M., Akiyama Y. Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats. J Bone Miner Metab 2007, 25:345-353.
39. Nash D., Magder L.S., Sherwin R., Rubin R.J., Silbergeld E.K. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2004, 160:901-911.
40. Webber C.E., Chettle D.R., Bowins R.J., Beaumont L.F., Gordon C.L., Song X., et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect 1995, 103(12):1150-1153.
41. Hunziker E.B., Schenk R.K. Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J Physiol 1989, 414:55-71.
42. Wronski T.J., Cintron M., Dann L.M. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 1988, 43:179-183.
43. Fatayerji D., Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res 1999, 14(7):1203-1210.
44. Shahnazari M., Dwyer D., Chu V., Asuncion F., Stolina M., Ominsky M., et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Bone 2012, 50:628-637.
45. O'Flaherty E.J. A physiologically based kinetic model for lead in children and adults. Environ Health Perspect 1998, 106(6):1495-1503.
46. Richardson R.B. A physiological skeletal model for radionuclide and stable element biokinetics in children and adults. Health Phys 2010, 99(4):471-482.